May 10 (Reuters) - Teva Pharmaceutical Industries (NYSE:TEVA) Ltd TEVA.TA :
* TEVA CANADA ANNOUNCES THE LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMULSION, THE FIRST GENERIC VERSION OF RESTASIS® IN CANADA FOR THE TREATMENT OF DRY EYE DISEASE
* TEVA CANADA LIMITED - LAUNCH OF TEVA-CYCLOSPORINE OPHTHALMIC EMULSION, 0.05% W/V IN CANADA